Search Results - "SAYLES, Leanne C"
-
1
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Published in Nature medicine (01-10-2015)“…The bromodomain and extraterminal (BET) inhibitor JQ1 synergizes with the histone deacetylase inhibitor SAHA to suppress tumor growth in mouse models of…”
Get full text
Journal Article -
2
Genome-Informed Targeted Therapy for Osteosarcoma
Published in Cancer discovery (01-01-2019)“…Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially unchanged for more than 30 years. Osteosarcoma is characterized by…”
Get more information
Journal Article -
3
Molecular definition of a metastatic lung cancer state reveals a targetable CD109–Janus kinase–Stat axis
Published in Nature medicine (01-03-2017)“…In vivo screening of pro-metastatic factors in a genetically engineered mouse model of lung cancer uncovered the CD109–JAK–STAT3 axis as a key contributor of…”
Get full text
Journal Article -
4
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
Published in Nature communications (21-02-2017)“…KRAS mutated tumours represent a large fraction of human cancers, but the vast majority remains refractory to current clinical therapies. Thus, a deeper…”
Get full text
Journal Article -
5
Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
Published in Nature medicine (01-11-2019)“…Proinflammatory cytokines in the tumor microenvironment can promote tumor growth, yet their value as therapeutic targets remains underexploited. We validated…”
Get full text
Journal Article -
6
Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo
Published in Cancer research (Chicago, Ill.) (15-11-2012)“…Cancer-associated fibroblasts (CAF) have been reported to support tumor progression by a variety of mechanisms. However, their role in the progression of…”
Get full text
Journal Article -
7
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Published in Genes & development (15-04-2010)“…Chemotherapy resistance is a major obstacle in cancer treatment, yet the mechanisms of response to specific therapies have been largely unexplored in vivo…”
Get full text
Journal Article -
8
A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
Published in Cancer cell (01-07-2013)“…Sustained tumor progression has been attributed to a distinct population of tumor-propagating cells (TPCs). To identify TPCs relevant to lung cancer…”
Get full text
Journal Article -
9
Introduction of an Additional Pathway for Lactate Oxidation in the Treatment of Lactic Acidosis and Mitochondrial Dysfunction in Caenorhabditis elegans
Published in Proceedings of the National Academy of Sciences - PNAS (20-12-2005)“…Mitochondrial dysfunction, with an estimated incidence of 1 in 5,000 births, is associated with a wide variety of multisystem degenerative diseases. Among the…”
Get full text
Journal Article -
10
Pharmacologic inhibition of eIF4A blocks NRF2 synthesis to prevent osteosarcoma metastasis
Published in Clinical cancer research (01-10-2024)“…Effective therapies for metastatic osteosarcoma (OS) remain a critical unmet need. Targeting mRNA translation in metastatic OS offers a promising option, as…”
Get full text
Journal Article -
11
Direct transposition of native DNA for sensitive multimodal single-molecule sequencing
Published in Nature genetics (01-06-2024)“…Concurrent readout of sequence and base modifications from long unamplified DNA templates by Pacific Biosciences of California (PacBio) single-molecule…”
Get full text
Journal Article -
12
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Published in Cancer cell (10-04-2023)“…Pediatric solid and central nervous system tumors are the leading cause of cancer-related death among children. Identifying new targeted therapies necessitates…”
Get full text
Journal Article -
13
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Published in The Journal of clinical investigation (01-04-2020)“…Few therapies are currently available for patients with KRAS-driven cancers, highlighting the need to identify new molecular targets that modulate central…”
Get full text
Journal Article -
14
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach
Published in Clinical cancer research (16-02-2024)“…Models to study metastatic disease in rare cancers are needed to advance preclinical therapeutics and to gain insight into disease biology. Osteosarcoma is a…”
Get full text
Journal Article -
15
Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation
Published in Molecular & cellular proteomics (01-07-2022)“…Since the discovery of oncogenes, there has been tremendous interest to understand their mechanistic basis and to develop broadly actionable therapeutics. Some…”
Get full text
Journal Article -
16
-
17
A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal
Published in Cancer cell (08-07-2013)“…Sustained tumor progression has been attributed to a distinct population of tumor-propagating cells (TPCs). To identify TPCs relevant to lung cancer…”
Get full text
Journal Article -
18
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models
Published in The Journal of clinical investigation (01-11-2010)“…KRAS is one of the most frequently mutated human oncogenes. In some settings, oncogenic KRAS can trigger cellular senescence, whereas in others it produces…”
Get full text
Journal Article -
19
A 3D Osteosarcoma Model with Bone‐Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug Discovery
Published in Advanced healthcare materials (01-09-2022)“…Osteosarcoma (OS) is an aggressive bone cancer for which survival has not improved over three decades. While biomaterials have been widely used to engineer 3D…”
Get full text
Journal Article -
20
Expression of Ndi1p, an alternative NADH:ubiquinone oxidoreductase, increases mitochondrial membrane potential in a C. elegans model of mitochondrial disease
Published in Biochimica et biophysica acta (01-09-2007)“…The NADH:ubiquinone oxidoreductase or complex I of the mitochondrial respiratory chain is an intricate enzyme with a vital role in energy metabolism. Mutations…”
Get full text
Journal Article